Cargando…
Virtual randomized study comparing lobectomy and particle beam therapy for clinical stage IA non-small cell lung cancer in operable patients
To the best of our knowledge there have been no randomized controlled trials comparing lobectomy—a standard treatment for patients with early-stage non-small cell lung cancer (NSCLC)—and particle beam therapy (PBT), the best performing existing radiotherapy. We conducted a virtual randomized trial i...
Autores principales: | Seo, Young-Seok, Park, Woo-Yoon, Kim, Si-Wook, Kim, Dohun, Min, Byung Jun, Kim, Won-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438263/ https://www.ncbi.nlm.nih.gov/pubmed/34218277 http://dx.doi.org/10.1093/jrr/rrab060 |
Ejemplares similares
-
Lobectomy versus stereotactic ablative radiotherapy for medically operable patients with stage IA non‐small cell lung cancer: A virtual randomized phase III trial stratified by age
por: Seo, Young‐Seok, et al.
Publicado: (2019) -
Survival after wedge resection versus lobectomy for stage IA second primary NSCLC with previous lung cancer-directed surgery
por: Song, Congkuan, et al.
Publicado: (2022) -
Comparison of Lobectomy and Sublobar Resection for Stage IA Elderly NSCLC Patients (≥70 Years): A Population-Based Propensity Score Matching’s Study
por: Zhang, Bo, et al.
Publicado: (2021) -
Sublobar resection versus lobectomy in solid-type, clinical stage IA, non-small cell lung cancer
por: Jeon, Hyun Woo, et al.
Publicado: (2014) -
Lobectomy versus segmentectomy for stage IA3 (T1cN0M0) non-small cell lung cancer: a meta-analysis and systematic review
por: Zhang, Wanfei, et al.
Publicado: (2023)